421,820 Shares in Phreesia, Inc. (NYSE:PHR) Purchased by Victory Capital Management Inc.

Victory Capital Management Inc. bought a new stake in Phreesia, Inc. (NYSE:PHR - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 421,820 shares of the company's stock, valued at approximately $10,782,000. Victory Capital Management Inc. owned 0.72% of Phreesia as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in PHR. Johnson Financial Group Inc. increased its stake in shares of Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after buying an additional 896 shares during the period. Quarry LP increased its stake in shares of Phreesia by 210.9% in the 4th quarter. Quarry LP now owns 2,835 shares of the company's stock valued at $71,000 after buying an additional 1,923 shares during the period. KBC Group NV acquired a new stake in shares of Phreesia in the 1st quarter valued at $74,000. CWM LLC increased its stake in shares of Phreesia by 994.9% in the 1st quarter. CWM LLC now owns 4,040 shares of the company's stock valued at $103,000 after buying an additional 3,671 shares during the period. Finally, NewEdge Advisors LLC increased its stake in shares of Phreesia by 12.1% in the 4th quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock valued at $107,000 after buying an additional 459 shares during the period. 92.10% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

PHR has been the subject of several research reports. Citigroup reissued a "buy" rating on shares of Phreesia in a research note on Wednesday, May 28th. Truist Financial raised their price target on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research report on Thursday, May 29th. Wall Street Zen upgraded Phreesia from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st. KeyCorp raised their price target on Phreesia from $28.00 to $35.00 and gave the stock an "overweight" rating in a research report on Monday, July 14th. Finally, Canaccord Genuity Group reduced their price target on Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a research report on Thursday, May 29th. Eleven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $32.27.

Insider Buying and Selling

In other news, General Counsel Allison C. Hoffman sold 1,245 shares of the business's stock in a transaction dated Thursday, July 17th. The stock was sold at an average price of $26.89, for a total value of $33,478.05. Following the sale, the general counsel directly owned 136,978 shares in the company, valued at $3,683,338.42. The trade was a 0.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Mark Douglas Smith sold 7,000 shares of the business's stock in a transaction dated Wednesday, July 2nd. The shares were sold at an average price of $29.00, for a total value of $203,000.00. Following the completion of the sale, the director owned 37,353 shares in the company, valued at approximately $1,083,237. This trade represents a 15.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 53,804 shares of company stock valued at $1,510,733. Corporate insiders own 5.50% of the company's stock.

Phreesia Trading Up 1.8%

PHR stock traded up $0.48 during midday trading on Monday, hitting $27.11. 313,253 shares of the company's stock were exchanged, compared to its average volume of 487,761. The stock's fifty day moving average price is $26.64 and its 200-day moving average price is $26.40. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.95 and a current ratio of 1.95. The company has a market cap of $1.61 billion, a PE ratio of -36.63 and a beta of 0.72. Phreesia, Inc. has a one year low of $17.07 and a one year high of $30.53.

Phreesia (NYSE:PHR - Get Free Report) last posted its earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.06. The firm had revenue of $115.94 million for the quarter, compared to analyst estimates of $115.00 million. Phreesia had a negative return on equity of 16.23% and a negative net margin of 9.83%. The company's revenue for the quarter was up 14.5% on a year-over-year basis. During the same period in the previous year, the company posted ($0.05) earnings per share. Research analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.